A 23-year-old Aboriginal man living in a remote community has a history of acute rheumatic fever and echocardiography-confirmed rheumatic mitral regurgitation. He is clinically well today. According to current Australian practice, what is the most appropriate ongoing secondary prophylaxis to reduce recurrent rheumatic fever and progression of rheumatic heart disease?